Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank50
3Y CAGR+13.3%
5Y CAGR-5.3%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+13.3%/yr
vs +7.3%/yr prior
5Y CAGR
-5.3%/yr
Recent acceleration
Acceleration
+6.0pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.55M | -47.0% |
| 2024 | $2.93M | -15.8% |
| 2023 | $3.48M | +225.7% |
| 2022 | $1.07M | +72.3% |
| 2021 | $620000.00 | -69.7% |
| 2020 | $2.04M | -6.6% |
| 2019 | $2.19M | +171.5% |
| 2018 | $806000.00 | - |
| 2017 | $0.00 | - |